Clinical Trials Logo

Filter by:
NCT ID: NCT01452672 Recruiting - Breast Cancer Clinical Trials

Resource-sparing Post-mastectomy Radiotherapy in Breast Cancer

Start date: March 2007
Phase: Phase 3
Study type: Interventional

This study compares two different field set-ups in patients with breast cancer following a breast resection (mastectomy). These two set-ups are as follows: arm a - radiotherapy to the chest-wall only, and arm b - radiotherapy to the chest-wall and the supraclavicular fossa. Patients in both treatment arms will receive radiotherapy with a shortened fractionation schedule. Study hypothesis: irradiation of the chest-wall only is not inferior to irradiation of the chest-wall and supraclavicular fossa in terms of loco-regional control, survival and treatment toxicity.

NCT ID: NCT01285726 Completed - Clinical trials for Chronic Renal Failure

Initiative for Patient Outcomes in Dialysis - Peritoneal Dialysis (PD) (IPOD-PD Study)

IPOD-PD
Start date: January 2011
Phase: N/A
Study type: Observational

The aim of the study is to asses the hydration status of incident peritoneal dialysis (PD) patients and its evolution over a period of four years, independent of the PD treatment modality (APD or CAPD) and the PD solution type.

NCT ID: NCT01145170 Completed - Clinical trials for Diffuse Intrinsic Brainstem Gliomas

Nimotuzumab and Radiotherapy in Pediatric Patients With Glioma

POLARIS
Start date: March 2011
Phase: Phase 2
Study type: Interventional

The study consists in only one treatment group, which will receive the first-line therapy for the disease - standard radiotherapy and a 150 mg/m2 dose of the investigational product (nimotuzumab)

NCT ID: NCT01111344 Completed - Clinical trials for External Anogenital Warts

Glizigen-Viudid-External Anogenital Warts in Children and Adolescents

Start date: December 2010
Phase: Phase 3
Study type: Interventional

The purpose of the study is to assess the efficacy of Glizigen and Viusid administration in the treatment of external anogenital warts in children and adolescents. The duration of this double-blind placebo controlled phase 3 clinical trial will be 12 weeks. The estimated number of persons to be recruited and randomized for the study is 76. Variables to be assessed will be: time to disappearance of lesions, reduction of the number of lesions and change in the aspect of lesions.

NCT ID: NCT01099319 Completed - Cholelithiasis Clinical Trials

Renalof in the Treatment of Elderly Patients With Gallstones

Start date: January 2010
Phase: Phase 3
Study type: Interventional

The purpose of this study is to assess the efficacy and safety of Renalof administration in the treatment of gallstones (cholelithiasis) as determined by ultrasonography and clinical evaluation in elderly patients (aged >65 years). The duration of this double-blind placebo controlled phase 3 clinical trial will be 6 months. The estimated number of patients to be recruited and randomized for the study is 40.

NCT ID: NCT01052064 Recruiting - Clinical trials for Attention Deficit Hyperactivity Disorder

Transcranial Magnetic Stimulation in Children With Attention Deficit Hyperactivity Disorder (ADHD). A Safety Study

Start date: April 2009
Phase: Phase 1
Study type: Interventional

Low frequency repetitive Transcranial Magnetic Stimulation(rTMS) is a safe and tolerable procedure in children with Attention Deficit Hyperactivity Disorder(ADHD); it also could be a complement to the treatment of patients with poor symptomatic control to conventional treatment.

NCT ID: NCT01051024 Completed - Clinical trials for Polycystic Ovary Syndrome

Diamel in the Treatment of Polycystic Ovary Syndrome

Start date: November 2009
Phase: Phase 3
Study type: Interventional

The purpose of this study is to assess the efficacy of Diamel administration in the treatment of Polycystic Ovary Syndrome. The duration of this double-blind placebo controlled phase 3 clinical trial will be 24 weeks.

NCT ID: NCT01043367 Completed - Depression Clinical Trials

Deprexil in Subjects With Signs and Symptoms of Depression

Start date: January 2010
Phase: Phase 3
Study type: Interventional

The purpose of the study is to assess the efficacy of DEPREXIL administration in combination with relaxation psychotherapy in the treatment of patients with signs and symptoms of depression. The duration of this double-blind placebo controlled phase 3 clinical trial will be 24 weeks. The estimated number of persons to be recruited and randomized for the study is 200.

NCT ID: NCT01025115 Completed - Metabolic Syndrome Clinical Trials

Diamel in the Treatment of Metabolic Syndrome

Start date: March 2009
Phase: Phase 3
Study type: Interventional

The purpose of this study is to assess the efficacy of Diamel administration in the treatment of Metabolic Syndrome. The duration of this double-blind placebo controlled phase 3 clinical trial will be 12 months.

NCT ID: NCT01022060 Completed - Clinical trials for Recurrent Calcic Urolithiasis

Renalof in the Dissolution of Renal Calculi in Patients With Recurrent Calcic Lithiasis

Start date: November 2009
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether Renalof administration promotes partial or total dissolution of urinary calculi and improves physicochemical parameters and metabolic activity in patients with recurrent calcic urolithiasis. The duration of this double-blind placebo controlled phase 3 clinical trial will be 12 weeks. The estimated number of patients to be recruited and randomized for the study is 110. Ultrasonographic and humoral parameters will be assessed every 4 weeks.